Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Endocrine ; 53(2): 364-72, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27270407

RESUMEN

The glucose-lowering pharmacopeia continues to grow for patients with type 2 diabetes. The latest drug category, the SGLT2 inhibitors reduce glycated hemoglobin concentrations by increasing urinary excretion of glucose. They are used mainly in combination with metformin and other antihyperglycemic agents, including insulin. Their glucose-lowering potency is modest. Advantages include lack of hypoglycemia as a side effect, and mild reduction in blood pressure and body weight. Side effects include increased urinary frequency, owing to their mild diuretic action, symptoms of hypovolemia, genitourinary infections. There are also recent reports of rare cases of diabetic ketoacidosis occurring in insulin-treated patients. Recently, a large cardiovascular outcome trial reported that a specific SGLT2 inhibitor, empagliflozin, led to a reduction in the primary endpoint of major cardiovascular events. This effect was mainly the result of a surprising 38 % reduction in cardiovascular death, and the drug was also associated with nearly as large a reduction in heart failure hospitalization. These findings were notable because most drugs used in type 2 diabetes have not been shown to improve cardiovascular outcomes. Accordingly, there is growing interest in empagliflozin and the entire SGLT2 inhibitor class as drugs that could potentially change the manner in which we approach the management of hyperglycemia in patients with type 2 diabetes.


Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hemoglobina Glucada/análisis , Hipoglucemiantes/uso terapéutico , Inhibidores del Cotransportador de Sodio-Glucosa 2 , Diabetes Mellitus Tipo 2/sangre , Quimioterapia Combinada , Humanos , Metformina/uso terapéutico , Resultado del Tratamiento
2.
AJNR Am J Neuroradiol ; 36(8): 1536-41, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25882280

RESUMEN

BACKGROUND AND PURPOSE: Abnormal signal intensity of the optic nerve due to diffusion restriction may be seen in traumatic optic neuropathy. In addition to evaluating optic nerve hyperintensity on diffusion-weighted imaging, we compared the group differences of ADC values between the injured and uninjured contralateral nerve and identified the relation between measured ADC values and admission visual acuity. MATERIALS AND METHODS: We retrospectively evaluated 29 patients with traumatic optic neuropathy who underwent MR imaging with DWI. Uninjured contralateral optic nerves were used as controls. Two attending radiologists, blinded to the side of injury, independently reviewed the DWI for the presence of signal-intensity abnormality and obtained ADC values after manually selecting the ROI. RESULTS: Hyperintensity of the optic nerve was demonstrated in 8 of the 29 patients, with a sensitivity of 27.6% (95% CI, 12.8-47.2) and a specificity of 100% (95% CI, 87.9-100). ADC values were obtained in 25 patients. The mean ADC in the posterior segment of the injured nerve was significantly lower than that in the contralateral uninjured nerve (Welch ANOVA, F = 9.7, P = .003). There was a moderate-to-strong correlation between low ADC values and poor visual acuity in 10 patients in whom visual acuity could be obtained at admission (R = 0.7, P = .02). Patients with optic nerve hyperintensity presented with worse visual acuity. CONCLUSIONS: Hyperintensity of the optic nerve due to diffusion restriction can serve as a specific imaging marker of traumatic optic neuropathy. When paired with reduced ADC values, this finding may be an important surrogate for visual acuity.


Asunto(s)
Imagen de Difusión por Resonancia Magnética/métodos , Neuroimagen/métodos , Traumatismos del Nervio Óptico/patología , Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
3.
Ann R Coll Surg Engl ; 92(7): 619-22, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20615300

RESUMEN

INTRODUCTION: The Ganz trochanteric flip approach aims to avoid the potential risk of avascular necrosis in hip conserving surgery and may reduce the risk of femoral neck fractures, neck thinning and femoral head implant migration in hip resurfacing. Our initial audit revealed the complications of non-union and trochanteric screw irritation to be associated with this approach. We, therefore, modified our selection criteria and re-audited our results. SUBJECTS AND METHODS: The initial audit (IA) ran between January 2003 and November 2007 after which an age limit of 50 years was recommended. The re-audit (RA) ran between November 2007 and December 2008 where one of the senior authors stopped using the approach in the over 50 year age group whilst the other senior author continued on selected patients over 50 years. RESULTS: There were 545 hips in the IA and 152 hips in the RA group. The incidence of non-union decreased in the RA after the change of selection criteria (6.2% [IA] vs 1.3% [RA]). In both audit groups, the incidence of non-union increased with age, and in the RA no non-unions were observed under the age of 50 years. The incidence of screw irritation and the necessity for removal remained relatively unchanged (20.7% [IA] vs 28.3% [RA]) with a combined incidence of 22.4%. CONCLUSIONS: The trochanteric flip approach to the hip can be used safely with an acceptable complication rate in young adult impingement and resurfacing surgery. Caution must, however, be exercised in patients over 50 years of age as they have a higher incidence of trochanteric non-union. In addition, all patients should be consented for the possibility of screw removal as a second procedure.


Asunto(s)
Artroplastia de Reemplazo de Cadera/métodos , Osteotomía/métodos , Adolescente , Adulto , Factores de Edad , Anciano , Artroplastia de Reemplazo de Cadera/efectos adversos , Tornillos Óseos/efectos adversos , Niño , Cabeza Femoral/irrigación sanguínea , Necrosis de la Cabeza Femoral/prevención & control , Articulación de la Cadera/diagnóstico por imagen , Humanos , Auditoría Médica , Persona de Mediana Edad , Osteotomía/efectos adversos , Radiografía , Adulto Joven
4.
Indian J Psychol Med ; 32(1): 49-53, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21799560

RESUMEN

The present investigation was aimed at studying the efficacy of cognitive behavior therapy (CBT) in reducing the symptoms of stuttering and dysfunctional cognitions and in enhancing assertiveness and quality of life in clients with stuttering. Five clients with stuttering who met the inclusion criteria (male clients with diagnosis of stuttering) and exclusion criteria (clients with brian damage), substance abuse or mental retardation were enrolled for the study. A single-case design was adopted. The pre-, mid- and post-assessment were carried out using Stuttering Severity Scale (SSI), Perception of Stuttering Inventory (PSI), Beck's Anxiety Inventory (BAI), Dysfunctional Attitude (DAS), Fear of Negative Evaluation (FNE), Assertiveness Scale (AS), Rosenberg's Self-Esteem Scale (RSES), and World Health Organization - Quality of Life Scale (WHO-QOL). Five clients received cognitive behavioral intervention comprising of psycho-education, relaxation, deep breathing, humming, prolongation, cognitive restructuring, problem-solving strategies and assertiveness. At post-treatment assessment, there was improvement. The findings of the study are discussed in the light of available research work, implications, limitations of the study and suggestions for future research.

5.
J Oleo Sci ; 58(12): 617-22, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19915318

RESUMEN

Mahua Oil (MO) is an underutilized non-edible vegetable oil, which is available in large quantities in India. In the present work, biodiesel was derived from the MO by the transesterification process. The fuel properties of the MO biodiesel were found to be within the limits of biodiesel specifications of many countries. The chemical nature of biodiesel makes it more susceptible to oxidation during long-term storage which leads to degradation of fuel properties that can compromise fuel quality. The effect of long storage condition on the stability of the MO biodiesel was studied in the present work. The biodiesel samples were stored in plastic containers at room temperature. The study was conducted for a period of 12 months and the test sample was kept in the darkness. From the experimental results, it was observed that the acid value and viscosity increases with the storage time, but the iodine value decreased with increasing storage time. This is due to the presence of the double bond in the molecule of the biodiesel which produce a high level of reactivity. This high level reactivity produces formation of hydroperoxides, soluble polymers and other secondary products. From the experimental results, a slight difference in the acid value, iodine value and viscosity of the MO biodiesel stored for a period of 30 days was observed. But after this period, the differences were significant.


Asunto(s)
Biocombustibles , Madhuca , Esterificación , Yodo/análisis , Aceites de Plantas/química
6.
Indian J Public Health ; 53(1): 41-3, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19806829

RESUMEN

Infant and child mortality, including deaths due to vaccine-preventable diseases, remains high in the rural areas of India. In Andhra Pradesh, the immunisation coverage of children in the 12-23 month age-group has progressively declined to 43%, indicating the immediate need for taking corrective steps. The Rural Effective Affordable Comprehensive Healthcare (REACH) project, based on the health metrics strategy was initiated to improve childhood immunisation coverage. Information on the immunisation status of children was recorded and each child was tracked with the help of a computerised database to provide timely immunisation. The health metrics strategy resulted in complete immunisation (96%) of all the 698 children in the 12-23 month age-group residing in the villages of the Medchal Mandal in the year 2007, as compared to 43% reported by the National Family Health Survey-3. Action oriented health metrics coupled with information technology can thereby improve childhood immunisation significantly.


Asunto(s)
Programas de Inmunización/métodos , Población Rural , Agentes Comunitarios de Salud , Humanos , Esquemas de Inmunización , India , Lactante , Sistemas de Registros Médicos Computarizados
7.
J Environ Sci Eng ; 51(3): 223-6, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21117439

RESUMEN

The world is confronted with fossil fuel depletion and environmental degradation. The energy demand and pollution problems lead to research for an alternative renewable energy sources. Vegetable oils and biodiesel present a very promising alternative fuel to diesel. In this work, an experimental work was carried out to study the feasibility of using raw mahua oil (MO) as a substitute for diesel in dual fuel engine. A single cylinder diesel engine was modified to work in dual fuel mode and liquefied petroleum gas (LPG) was used as primary fuel and mahua oil was used as pilot fuel. The results show that the performance of the dual fuel engine at the injector opening pressure of 220 bar and the advanced injection timing of 30 degrees bTDC results in performance close to diesel base line (DBL) operation and lower smoke and oxides of nitrogen emission.


Asunto(s)
Ácidos Grasos , Biomasa , India
8.
J Indian Soc Pedod Prev Dent ; 23(1): 31-4, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15858304

RESUMEN

Hypohidrotic ectodermal dysplasia is a rare congenital disease that affects several ectodermal structures. The condition is usually transmitted as an x-linked recessive trait, in which gene is carried by the females and manifested in males. Manifestations of the disease differ in severity and involve teeth, skin, hair, nails and sweat and sebaceous gland. Ectodermal dysplasia is usually a difficult condition to manage. Prosthodontically, because of the typical oral deficiencies, and afflicted individuals are quite young to receive extensive prosthodontic treatment, which restores their appearance and helps them, for the development of positive self-image. This case report describes the management of upper jaw with over denture with copings on existing teeth i.e. two permanent peg shaped centrals as well as lateral incisors. However with adequate of retainer lower denture was provided with a new treatment modality.


Asunto(s)
Anodoncia/rehabilitación , Diseño de Dentadura , Prótesis de Recubrimiento , Displasia Ectodermal Anhidrótica Tipo 1/rehabilitación , Desarrollo Maxilofacial , Factores de Edad , Anodoncia/etiología , Niño , Pilares Dentales , Displasia Ectodermal Anhidrótica Tipo 1/complicaciones , Estética Dental , Humanos , Masculino , Mandíbula , Maxilar , Resultado del Tratamiento
9.
Vaccine ; 18(19): 2009-14, 2000 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-10706962

RESUMEN

Sixty rural children who were seronegative for HBV markers received three doses of 10 microgram of a new Hepatitis-B vaccine, Revac-B (1 ml of vaccine contains 20 microgram recombinant surface antigen) that was formulated from hepatitis-B surface antigen expressed in a recombinant strain of Saccharomyces cerevisiae. Vaccines were administered on a 0, 30 and 60-day schedule. Levels of anti-HBs titres were determined on the 30th, 60th and 90th days following the initial injection. None of the participants in the trial had serious adverse reactions and the frequencies of minor side effects were minimal. No clinically important adverse effects which could be considered as directly related to the vaccination were recorded. The volunteers showed a very good immune response and were seroprotected on the 30th day after the first dose of vaccination. The present study revealed that the new vaccine, Revac-B is highly immunogenic and is well tolerated.


Asunto(s)
Vacunas contra Hepatitis B/farmacología , Trastornos Nutricionales/inmunología , Niño , Preescolar , Femenino , Anticuerpos contra la Hepatitis B/biosíntesis , Anticuerpos contra la Hepatitis B/sangre , Vacunas contra Hepatitis B/efectos adversos , Vacunas contra Hepatitis B/inmunología , Humanos , Esquemas de Inmunización , India , Masculino , Población Rural , Seguridad , Vacunas Sintéticas/efectos adversos , Vacunas Sintéticas/inmunología , Vacunas Sintéticas/farmacología
10.
Indian Heart J ; 51(2): 167-72, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10407544

RESUMEN

Primary angioplasty has been shown to reduce rates of in-hospital mortality, recurrent ischaemia and infarction. However, the role of primary stenting and abciximab is presently undergoing evaluation. This study attempted to examine the feasibility, safety and outcomes of primary angioplasty in the treatment of acute myocardial infarction. Data in 100 patients who underwent primary angioplasty for evolving acute myocardial infarction was prospectively analysed to assess the safety and efficacy of various modalities. Twenty patients were in Killip class III and above. Multivessel (2 or more vessels) disease was noted in more than 52 cases. Procedural success was 99 percent; 86 patients received primary stenting, majority of them had Kalam-Raju stent implantation. Adjunct treatment included abciximab infusion in 22 and intra-aortic balloon pump support in 12. Overall mortality rate was six percent with a mortality of 2.2 percent in non-cardiogenic shock patients. Recurrent ischaemic events were noted in five, three of them had successful reperfusion with repeat angioplasty. None of the patients had emergency coronary artery bypass surgery. It is concluded that primary angioplasty is safe and effective with high procedural success. Recurrent ischaemic events are low, possibly due to routine use of stenting and selective use of abciximab.


Asunto(s)
Angioplastia Coronaria con Balón , Infarto del Miocardio/terapia , Abciximab , Adulto , Anticuerpos Monoclonales/uso terapéutico , Anticoagulantes/uso terapéutico , Angiografía Coronaria , Estudios de Factibilidad , Femenino , Hemodinámica , Humanos , Fragmentos Fab de Inmunoglobulinas/uso terapéutico , Masculino , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/fisiopatología , Estudios Prospectivos , Recurrencia , Stents , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA